An 89-year-old woman, living independently, presented to a community hospital with complaints of back pain and anterior chest pain after a fall at home. During her hospitalization, she was infected with COVID-19, and although her fever temporarily resolved with symptomatic treatment, she developed pancytopenia and liver dysfunction along with fever again. Blood tests and imaging studies ruled out acute cholangitis or hepatitis virus infection, and a diagnosis of myelosuppression and liver dysfunction due to multi-system inflammatory syndrome (MIS) was made. Treatment with prednisolone was initiated, and improvement in liver enzyme levels and pancytopenia was observed, indicating that steroid therapy was effective. Still, after steroid discontinuation, the patient again presented with pancytopenia. This case demonstrates the potential of multiorgan damage that can occur after a COVID-19 infection and emphasizes the importance of tapering and monitoring steroid therapy, especially in the management of myelosuppression and liver dysfunction due to MIS, during a COVID-19 infection. This may contribute to improved patient prognosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11605485PMC
http://dx.doi.org/10.7759/cureus.72681DOI Listing

Publication Analysis

Top Keywords

liver dysfunction
12
myelosuppression liver
8
steroid therapy
8
covid-19 infection
8
liver
5
pancytopenia
4
pancytopenia acute
4
acute liver
4
liver failure
4
failure caused
4

Similar Publications

Therapeutic hypothermia in preterm infants under 36 weeks: Case series on outcomes and brain MRI findings.

Eur J Pediatr

January 2025

Neonatology Department. Hospital Sant Joan de Déu, Center for Maternal Fetal and Neonatal Medicine. Neonatal Brain Group, Universitat de Barcelona. Hospital Clínic, Universitat de Barcelona. BCNatal - Barcelona, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.

Purpose: Perinatal hypoxic-ischemic encephalopathy (HIE) is a significant cause of neonatal brain injury. Therapeutic hypothermia (TH) is the standard treatment for term neonates, but its safety and efficacy in neonates < 36 weeks gestational age (GA) remains unclear. This case series aimed to evaluate the outcomes of preterm infants with HIE treated with TH.

View Article and Find Full Text PDF

ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis.

Am J Gastroenterol

January 2025

Kennth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease of the esophagus. It is diagnosed in the setting of symptoms of esophageal dysfunction and an eosinophilic predominant infiltrate in the esophagus. The condition is rapidly increasing in incidence and prevalence and is commonly encountered in gastroenterology and allergy practices, emergency departments, and primary care settings.

View Article and Find Full Text PDF

Introduction: In solid-organ transplant (SOT) recipients, while survival rates have improved with immunosuppressive therapies, the risk of opportunistic infections has also increased. This study aimed to evaluate the frequency of pneumonia, identify microbiological factors, investigate diagnostic methods, and analyse prognosis.

Materials And Methods: A retrospective study was conducted to identify adult SOT recipients referred to the pulmonary diseases department with a preliminary pneumonia diagnosis between 2011 and 2019.

View Article and Find Full Text PDF

The dual role of reactive oxygen species (ROS) in various liver diseases leads to the potential of nanomaterials in addressing challenges related to liver conditions. Considering the pivotal role of ROS in liver disease progression, the design and application of nanomaterials need to align with distinct disease characteristics and the unique liver microenvironment. By reviewing the interaction between nanomaterials and ROS in liver diseases and their potential applications in liver disease treatment, this work discusses the multifaceted properties of nanomaterials and their high specificity and prospects in liver disease treatments.

View Article and Find Full Text PDF

Budd-Chiari syndrome (BCS) is a rare, potentially lifethreatening condition characterised by obstruction of the hepatic venous outflow tract due to thrombosis. Treatment typically involves lifelong anticoagulation and relieving the obstruction. This case report introduces hepatic venous thromboaspiration as an additional endovascular technique to achieve recanalisation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!